<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD11090000_1</Organism_ID>
  <Organism>Nostoc ellipsosporum</Organism>
  <Organism_Latin>Nostoc ellipsosporum</Organism_Latin>
  <UniProt_ID>P81180</UniProt_ID>
  <Seq_Length>101</Seq_Length>
  <Molecule_Weight>11013</Molecule_Weight>
  <Function_Summary>Mannose-binding lectin.</Function_Summary>
  <Pfam_ID>PF08881:CVNH</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CV-N</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any mono-, di- or trisaccharide carbohydrate.</Detail>
      <Keyword>Sugar binding</Keyword>
      <Ontology_ID>GO:0005529</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any carbohydrate, any of a group of organic compounds based of the general formula Cx(H2O)y.</Detail>
      <Keyword>Carbohydrate binding</Keyword>
      <Ontology_ID>GO:0030246</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the antiviral response of a cell or organism.</Detail>
      <Keyword>Regulation of defense response to virus</Keyword>
      <Ontology_ID>GO:0050688</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>LGKFSQTCYNSAIQGSVLTSTCERTNGGYNTSSIDLNSVIENVDGSLKWQPSNFIETCRNTQLAGSSELAAECKTRAQQFVSTKINLDDHIANIDGTLKYE</Protein_Seq>
  </Molecule_Seq>
  <molGene/>
  <PDB_List>
    <PDB>
      <PDB_Title>Structure of P51G Cyanovirin-N swapped tetramer in the C2 space group</PDB_Title>
      <PDB_ID>4J4G</PDB_ID>
      <Resolution>1.92</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4J4G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Different 3D domain-swapped oligomeric cyanovirin-N structures suggest trapped folding intermediates.</PubMed_Title>
      <Author>Koharudin, L.M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:7702-7707</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23610431?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of P51G Cyanovirin-N swapped trimer in the P212121 space group</PDB_Title>
      <PDB_ID>4J4E</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4J4E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Different 3D domain-swapped oligomeric cyanovirin-N structures suggest trapped folding intermediates.</PubMed_Title>
      <Author>Koharudin, L.M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:7702-7707</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23610431?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of a Five Site Mutated Cyanovirin-N with a Mannose Dimer Bound at 1.8 A Resolution</PDB_Title>
      <PDB_ID>2PYS</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PYS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Monovalent Mutant of Cyanovirin-N Provides Insight into the Role of Multiple Interactions with gp120 for Antiviral Activity.</PubMed_Title>
      <Author>Fromme, R., et al.</Author>
      <Journal>Biochemistry(2007)46:9199-9207</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17636873?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Cyanovirin-N domain B mutant</PDB_Title>
      <PDB_ID>3CZZ</PDB_ID>
      <Resolution>1.36</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CZZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping.</PubMed_Title>
      <Author>Matei, E., et al.</Author>
      <Journal>Structure(2008)16:1183-1194</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18682220?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CYANOVIRIN-N</PDB_Title>
      <PDB_ID>3EZM</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EZM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping.</PubMed_Title>
      <Author>Yang, F., et al.</Author>
      <Journal>J.Mol.Biol.(1999)288:403-412</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10329150?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of cyanovirin-n complexed to a synthetic hexamannoside</PDB_Title>
      <PDB_ID>3GXY</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GXY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of the complexes of a potent anti-HIV protein cyanovirin-n and high mannose oligosaccharides</PubMed_Title>
      <Author>Botos, I., et al.</Author>
      <Journal>J.Biol.Chem.(2002)277:34336-34342</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12110688?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure an Tandem Cyanovirin-N Dimer, CVN2L10</PDB_Title>
      <PDB_ID>3S3Z</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S3Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Designed oligomers of cyanovirin-N show enhanced HIV neutralization.</PubMed_Title>
      <Author>Keeffe, J.R., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2011)108:14079-14084</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21799112?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution NMR Structure of Complex of 1:2 Cyanovirin-N:Man-Alpha1,2-Man-Alpha Restrained Regularized Mean Coordinates</PDB_Title>
      <PDB_ID>1IIY</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IIY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution Structure of a Cyanovirin-N:Man alpha 1-2Man alpha Complex. Structural Basis for High Affinity Carbohydrate-Mediated Binding to gp120</PubMed_Title>
      <Author>Bewley, C.A., et al.</Author>
      <Journal>Structure(2001)9:931-940</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11591348?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The domain-swapped dimer of CV-N in solution</PDB_Title>
      <PDB_ID>1L5E</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L5E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures.</PubMed_Title>
      <Author>Barrientos, L.G., et al.</Author>
      <Journal>Structure(2002)10:673-686</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12015150?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of cyanovirin-n swapping domain b mutant</PDB_Title>
      <PDB_ID>3LHC</PDB_ID>
      <Resolution>1.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LHC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Anti-HIV activity of defective cyanovirin-N mutants is restored by dimerization.</PubMed_Title>
      <Author>Matei, E., et al.</Author>
      <Journal>J.Biol.Chem.(2010)285:13057-13065</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20147291?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DOMAIN-SWAPPED CYANOVIRIN-N DIMER</PDB_Title>
      <PDB_ID>1L5B</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L5B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures.</PubMed_Title>
      <Author>Barrientos, L.G., et al.</Author>
      <Journal>Structure(2002)10:673-686</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12015150?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution Structure of a Circular-Permuted Variant of the Potent HIV-inactivating Protein Cyanovirin-N</PDB_Title>
      <PDB_ID>1N02</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1N02</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution Structure of a Circular-Permuted Variant of the Potent HIV-inactivating Protein Cyanovirin-N:  Structural Basis for Protein Stability and Oligosaccharide Interaction</PubMed_Title>
      <Author>Barrientos, L.G., et al.</Author>
      <Journal>J.Mol.Biol.(2003)325:211-223</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12473463?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of P51G Cyanovirin-N swapped tetramer in the P212121 space group</PDB_Title>
      <PDB_ID>4J4F</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4J4F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Different 3D domain-swapped oligomeric cyanovirin-N structures suggest trapped folding intermediates.</PubMed_Title>
      <Author>Koharudin, L.M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:7702-7707</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23610431?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of P51G Cyanovirin-N swapped dimer in the P3221 space group</PDB_Title>
      <PDB_ID>4J4C</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4J4C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Different 3D domain-swapped oligomeric cyanovirin-N structures suggest trapped folding intermediates.</PubMed_Title>
      <Author>Koharudin, L.M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:7702-7707</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23610431?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of P51G Cyanovirin-N swapped dimer in the P21212 space group</PDB_Title>
      <PDB_ID>4J4D</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4J4D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Different 3D domain-swapped oligomeric cyanovirin-N structures suggest trapped folding intermediates.</PubMed_Title>
      <Author>Koharudin, L.M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:7702-7707</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23610431?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Five site mutated Cyanovirin-N with Mannose dimer bound</PDB_Title>
      <PDB_ID>2RDK</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RDK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution.</PubMed_Title>
      <Author>Fromme, R., et al.</Author>
      <Journal>Protein Sci.(2008)17:939-944</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18436959?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of a five site mutated Cyanovirin-N</PDB_Title>
      <PDB_ID>2Z21</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2Z21</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Monovalent Mutant of Cyanovirin-N Provides Insight into the Role of Multiple Interactions with gp120 for Antiviral Activity.</PubMed_Title>
      <Author>Fromme, R., et al.</Author>
      <Journal>Biochemistry(2007)46:9199-9207</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17636873?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure an Tandem Cyanovirin-N Dimer, CVN2L0</PDB_Title>
      <PDB_ID>3S3Y</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S3Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Designed oligomers of cyanovirin-N show enhanced HIV neutralization.</PubMed_Title>
      <Author>Keeffe, J.R., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2011)108:14079-14084</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21799112?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of cyanovirin-n complexed to oligomannose-9 (man-9)</PDB_Title>
      <PDB_ID>3GXZ</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GXZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides</PubMed_Title>
      <Author>Botos, I., et al.</Author>
      <Journal>J.Biol.Chem.(2002)277:34336-34342</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12110688?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CYANOVIRIN-N</PDB_Title>
      <PDB_ID>1J4V</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J4V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Using conjoined rigid body/torsion angle simulated annealing to determine the relative orientation of covalently linked protein domains from dipolar couplings.</PubMed_Title>
      <Author>Clore, G.M., et al.</Author>
      <Journal>J.Magn.Reson.(2002)154:329-335</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11846592?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION NMR STRUCTURE OF CYANOVIRIN-N ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES</PDB_Title>
      <PDB_ID>2EZN</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2EZN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of cyanovirin-N, a potent HIV-inactivating protein.</PubMed_Title>
      <Author>Bewley, C.A., et al.</Author>
      <Journal>Nat.Struct.Biol.(1998)5:571-578</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9665171?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CYANOVIRIN-N DOUBLE MUTANT P51S S52P</PDB_Title>
      <PDB_ID>1LOM</PDB_ID>
      <Resolution>1.72</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LOM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Domain-swapped structure of a mutant of cyanovirin-N.</PubMed_Title>
      <Author>Botos, I., et al.</Author>
      <Journal>Biochem.Biophys.Res.Commun.(2002)294:184-190</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12054761?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution Structure of Cyanovirin-N Domain B Mutant</PDB_Title>
      <PDB_ID>2RP3</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RP3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping</PubMed_Title>
      <Author>Matei, E., et al.</Author>
      <Journal>Structure(2008)16:1183-1194</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18682220?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION NMR STRUCTURE OF CYANOVIRIN-N, RESTRAINED REGULARIZED MEAN COORDINATES</PDB_Title>
      <PDB_ID>2EZM</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2EZM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of cyanovirin-N, a potent HIV-inactivating protein.</PubMed_Title>
      <Author>Bewley, C.A., et al.</Author>
      <Journal>Nat.Struct.Biol.(1998)5:571-578</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9665171?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/version/latest/cathnode/2</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Bewley CA, et al. Nat Struct Biol. 1998,5(7):571-578.;Yang F, et al. J Mol Biol. 1999,288(3):403-412.;Barrientos LG, et al. Structure. 2002,10(5):673-686.;Selwood T, et al. Arch Biochem Biophys. 2012,519(2):131-143.</Site_Reference>
      <Site_Type>Morpheein model</Site_Type>
      <PubMed_ID>9665171;10329150;12015150;22182754</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Create_Date>2013-11-07</Create_Date>
</Organism_Record>